Avigan Interim Analysis Not Intended to Determine Efficacy, Research Sponsor Says on Reports

May 21, 2020
On the heels of news reports that Fujifilm’s antiviral Avigan (favipiravir) failed to show clear efficacy against COVID-19 in interim analysis results from one of its clinical trials, the program’s sponsor issued a statement on May 20, stressing that the...read more